The predictive value of measuring immature platelet fraction (IPF) in the recovery from thrombocytopenia caused by chemotherapy in lung cancer patients

The predictive value of measuring immature platelet fraction (IPF) in the recovery from thrombocytopenia caused by chemotherapy in lung cancer patients - The predictive value of immature platelet fraction (IPF) in the recovery from thrombocytopenia in lung cancer chemotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005804

Enrollment

250

Registered

2011-06-22

Start date

2011-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lung cancer patients recieved chemotherapy

Exclusion criteria

Exclusion criteria: lung cancer patients not recieved chemotherapy

Design outcomes

Primary

Measure	Time frame
recovery from thronbocytopenia	—

Countries

Japan

Contacts

Public ContactShigeaki Ogura

Hokkaido Medical Center Department of Respirology

011-611-8111

Outcome results